Prostanoids modulate inflammation and alloimmune responses during graft rejection

• Main Authors: P.N. Rocha, E.M. Carvalho
• Format: Article
• Language: English
• Published: Associação Brasileira de Divulgação Científica 2005-12-01
• Series: Brazilian Journal of Medical and Biological Research
• Subjects: Thromboxane; Prostaglandins; Transplantation; Inflammation; Rejection; Corticosteroids
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2005001200004

Acute rejection of a transplanted organ is characterized by intense inflammation within the graft. Yet, for many years transplant researchers have overlooked the role of classic mediators of inflammation such as prostaglandins and thromboxane (prostanoids) in alloimmune responses. It has been demonstrated that local production of prostanoids within the allograft is increased during an episode of acute rejection and that these molecules are able to interfere with graft function by modulating vascular tone, capillary permeability, and platelet aggregation. Experimental data also suggest that prostanoids may participate in alloimmune responses by directly modulating T lymphocyte and antigen-presenting cell function. In the present paper, we provide a brief overview of the alloimmune response, of prostanoid biology, and discuss the available evidence for the role of prostaglandin E2 and thromboxane A2 in graft rejection.